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Lower platelet count early after the heart transplantation is asso-
ciated with lower rates of cellular-mediated rejection within 24 
months after heart transplantation
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Background: Decrease in platelet count following the induction with polyclonal anti-thymocyte globu-
lin (ATG) is deemed as an adverse event, while decrease in lymphocyte count represents a therapeutic 
goal1. Still, the effect on platelets may represent an important part of ATG anti-rejection mechanisms. 
Patients and Methods: This was a retrospective single-center study of consecutive HTx (heart trans-
plantation) patients (pts) from February 2010 to February 2018 in University Hospital Centre Zagreb. All 
pts received rATG (Thymoglobulin®) 1.5 mg/kg daily during the first 5 days. Complete blood count with 
differential was assessed on days 0, 7 and 14 after HTx. The incidence of cellular-mediated rejection 
(ACR) was monitored for two years after HTx. ACR was classified according to ISHLT classification from 
1990 and expressed as ACR of grade 1B or higher (≥1B). 
tAbLe 1. Univariate Analysis of Acute Cellular Rejection (ACR of grade ≥1B) in the first 2 years after 
heart transplantation.
Variable HR 95% CI p value
Recipient age, years 0.961 0.939-0.984 0.001
Recipient gender
Male 0.625 0.281-1.392 0.25
Positive pre-transplant recipient CMV IgG 0.319 0.133-0.766 0.011
Donor/recipient CMV mismatch 2.646 0.778-8.994 0.119
Donor age, years 0.971 0.943-1.001 0.059
Donor gender
Male 1.594 0.643-3.949 0.314
Pre-transplant mechanical circulatory support 1.677 0.573-4.908 0.345
Ischemia time, min 1.001 0.995-1.007 0.678
Absolute lymphocyte count on day 7, x 103/µL 1.000 0.999-1.002 0.446
Absolute lymphocyte count on day 14, x 103/µL 1.001 1.000-1.001 0.074
Platelet count on day 7, x 103/µL 1.007 1.002-1.013 0.006
Platelet count on day 14, x 103/µL 1.004 1.000-1.008 0.074
Positive post-transplant CMV PCR 0.501 0.118-2.127 0.349
Calcineurin inhibitor, No. (%)
Tacrolimus vs Cyclosporine 
0.840 0.393-1.796 0.653
CMV = Cytomegalovirus; PCR = polymerase chain reaction.
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Results: A total of 159 pts were transplanted. Median age was 55 years (IQR, 47-62 years), 76% were male. A total of 27 pts (17 %) experi-
enced ACR ≥1B during 24 months. Pts with ACR of grade ≥1B had higher platelet count on day 7 (145 vs 104 x 103/µL, p<0.001). They also 
had higher the absolute lymphocyte count (ALC) on the same day, but this did not reach statistical significance (162 vs 130 x 103/µL, 
p=0.19) and there was no correlation between ALC and platelet counts on day 7 (Pearson’s correlation coefficient was 0.064, p=0.459). 
Conversely, more rejection was observed in pts with higher ALC on day 14 (326 vs 190 x 103/µL, p=0.035), with a trend towards statisti-
cal significance in the relationship with higher platelet count (210 vs 199 x 103/µL, P=0.076). In the univariate analysis, higher platelet 
count on day 7, younger recipient age and negative pre-transplant Cytomegalovirus (CMV) IgG serology were found as predictors of the 
ACR ≥1B in the first 2 years after HTx (Table 1). In multivariable model, platelet count on day 7 and pre-transplant CMV serostatus were 
independent predictors of rejection. ROC analysis of the aforementioned model showed a satisfying AUC of 0.75. 
Conclusion: Decrease in platelet count following the induction with rATG is strongly related to less graft rejection that is independent 
from the lymphodepleting effect. This indicates the importance of platelet involvement in anti-rejection mechanisms of ATG induc-
tion, and consequently a possible rationale for targeting platelets in future immunosuppressive regimens.
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